The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) and The George Institute for Global Health have announced a new collaboration to improve outcomes in genitourinary cancers, with an initial focus on predicting which patients will benefit from radiation therapy after surgery for prostate cancer.